UNSPSC 85721815: Revision of infusion device in right toe phalangeal joint, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of infusion device in right toe phalangeal joint, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SWP33Z

UNSPSC 85721815 Revision of infusion device in right toe phalangeal joint, percutaneous approach is a Commodity code that shows no meaningful recent state and local procurement activity aligned with its nominal scope. The six recent opportunities tagged under this code—spanning independent medical evaluation services, pharmacy benefit management, surgical carve-out programs, occupational medical surveillance, youth detention healthcare, and temporary health professional staffing—do not involve infusion device revision procedures or orthopedic implant work. The code appears to be a mislabeling artifact in state and local procurement systems, where medical procedure terminology has been incorrectly applied to classify administrative healthcare services or staffing contracts rather than surgical interventions or device procurement.

Activity in the broader healthcare-services space is distributed across multiple jurisdictions and issuing bodies. The City of Phoenix Retirement Office (independent medical evaluations RFP, due October 16, 2026), City of Long Beach (surgical benefit carve-out RFP, due October 7, 2026), Washington State Department of Transportation (occupational medical surveillance RFP, due October 9, 2026), Harris County Juvenile Probation Department (emergency and specialty medical services RFI, due September 25, 2026), Collier County (pharmacy benefit management RFP, due April 9, 2026), and County of Santa Clara Health System (temporary health professional staffing qualification pool, due October 7, 2026) represent state departments, county and municipal health systems, and pension or safety agencies. The geographic footprint spans Arizona, California, Washington, Florida, and Texas. None of these opportunities represent procurement under the infusion device code itself; the mislabeling suggests that business development professionals should verify UNSPSC assignments in source materials before allocating pursuit resources to this particular Commodity code.